Effects of fingolimod treatments on alanine transaminase and aspartate transaminase levels in patients with multiple sclerosis.
Article in International Journal of Physiology, Pathophysiology and Pharmacology (June 2020)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Effect of fingolimod on platelet count among multiple sclerosis patients
Article in International Journal of Preventive Medicine (December 2015)